INS and Hypoglycemia: A recent systematic review and meta-analysis of basal and premixed regimens demonstrated that twice-daily premixed insulin regimens reduced HbA1c by an additional 0.45% (CI 0.19–0.70%), but with additional weight gain and higher rates of hypoglycemia [15].